CompletedNot applicableNCT01068795

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Studying Preeclampsia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
HaEmek Medical Center, Israel
Principal Investigator
Raed Salim, MD
Dep. OB/GYN, HaEmek Medical Center, Afula, Israel
Intervention
enoxaparin(drug)
Enrollment
144 target
Eligibility
18-45 years · FEMALE
Timeline
2009 – 2015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01068795 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia →

← Back to all trials